Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/2006
07/19/2006EP1370556B1 Metalloproteinase inhibitors
07/19/2006EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
07/19/2006EP1268453B1 Estrogen agonist/antagonist metabolites
07/19/2006EP1261315B1 Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
07/19/2006EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances
07/19/2006EP1075492B1 Melanocortin 1 receptor selective compounds
07/19/2006CN1805936A VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
07/19/2006CN1803178A Traditional Chinese medicine composition and its preparation method and quality control method
07/19/2006CN1803166A Capsule for blackening and generating hair, and its preparation process
07/19/2006CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use
07/19/2006CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity
07/19/2006CN1264824C Quinazoline derivatives
07/19/2006CN1264560C Medication for treating psoriasis and preparation method
07/19/2006CN1264549C Health-care food used for relaxing bowel, anti-senility and beautifying face
07/19/2006CN1264546C Prepared traditional medicine applied in tumor surgical operation, radiotheraphy and chemotherapy
07/19/2006CN1264542C Externally used medicine for treating burns and scalds
07/19/2006CN1264538C Itching relieving medicament
07/19/2006CN1264528C Spot dispelling capsule and its preparation method
07/19/2006CN1264526C Improved and stable extract from hypericum perforatuml, method for producing and uses as topical medicine
07/19/2006CN1264521C Nano selenium of chitin and its preparation method
07/19/2006CN1264510C Application of geldanamycin (C-3559) preparation of medicine for curing condyloma acuminatum
07/19/2006CN1264499C Cosmtics treatment using novel retinoid
07/18/2006USRE39199 Antipsoriatic compositions, method of making, and method of using
07/18/2006US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections
07/18/2006US7078438 N-(4 substituted phenyl)-anthranilic acid hydroxamate esters
07/18/2006US7078424 Central nervous system disorders; alopecia
07/18/2006US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders
07/18/2006US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents
07/18/2006US7078410 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring
07/18/2006US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants
07/18/2006US7078403 Antiviral agents
07/18/2006US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects
07/18/2006US7078398 Compositions and methods for treating or preventing convulsions or seizures
07/18/2006US7078223 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
07/18/2006US7078217 Aggrecanase molecules
07/18/2006US7078173 Assays and therapies for latent viral infection
07/18/2006US7078060 Contacting an area with a solution of atomically disordered, nanocrystalline metal, metal alloy or metal compound; drug delivery; microbiocides; bactericides; fungicides; anticarcinogenic, -tumor and -inflammatory agents; viricides
07/18/2006US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14
07/18/2006US7078047 Use of homopolymers and salts for moisturizing the skin, mucous membranes and/or keratin fibres, and/or as a moisturizer and/or emollient
07/18/2006CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses
07/13/2006WO2006073359A1 Topical compositions comprising one or more of 44-thiouridine, isomaltitol and uridine
07/13/2006WO2006073197A1 1-thio-d-glucitol derivatives
07/13/2006WO2006073190A1 Composition for external use
07/13/2006WO2006073181A1 Cell activator, cell death inhibitor and cell death promoter
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006073052A1 Novel angiogensis inhibitor
07/13/2006WO2006057902A3 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
07/13/2006WO2006057901A3 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
07/13/2006WO2006047522A8 Hypoestoxides, derivatives, agonists and crude extracts thereof for use in topical compositions
07/13/2006US20060154982 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases such as cancer, psoriasis, arteriosclerosis or is at risk of restenosis of the coronary arteries after vascular surgery
07/13/2006US20060154977 Therapeutic molecules and methods-1
07/13/2006US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment
07/13/2006US20060154972 Amino acids with affinity for the alpha-2-delta-protein
07/13/2006US20060154969 Adenosine receptor selective modulators
07/13/2006US20060154954 Combinations and use of selected pharmaceutically active compounds
07/13/2006US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma
07/13/2006US20060154933 Inhibitors of Cdc25 phosphatases
07/13/2006US20060154929 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds
07/13/2006US20060154928 Novel 2,4-diamino-1,3,5-triazine derivative
07/13/2006US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents
07/13/2006US20060153939 Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use
07/13/2006US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment
07/13/2006US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies
07/13/2006US20060153792 Novel cosmetic formulations based on a gel-forming and/or thickening agent and applications of same
07/13/2006US20060150988 Method of transdermal and transmucosal absorption of carbon dioxide and cosmetic method and therapeutic method
07/13/2006DE102004063494A1 Antikörper Antibody
07/12/2006EP1679316A1 Stable vitamin b6 derivative
07/12/2006EP1679078A1 A composition for treating chronic wounds
07/12/2006EP1679071A1 Collagen productin enhancer and production process and use thereof
07/12/2006EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives
07/12/2006EP1678170A1 Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
07/12/2006EP1496865B1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations
07/12/2006EP1487507B1 Wound dressing materials comprising chemically modified polysaccharides
07/12/2006EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction
07/12/2006EP1419118B1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
07/12/2006EP1392311B1 Pyrimidine derivatives as selective inhibitors of cox-2
07/12/2006EP1021159B1 Photoresponsive sunscreen compositions
07/12/2006EP0863744B1 Lipoic acid in topical compositions
07/12/2006EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders
07/12/2006CN1802357A Aminopyrimidine derivatives and their medical use
07/12/2006CN1802160A Use of heterocyclic compounds as SCCE inhibitors
07/12/2006CN1800171A Podocarpus extract and its preparation method
07/12/2006CN1799626A Recombined human interferon-gamma liposome gel and its application in treatment of condyloma acuminatum
07/12/2006CN1799607A Chinese medicinal compound prescription for treating chloasma
07/12/2006CN1799587A Compound whitening and spots-removing liquid
07/12/2006CN1799585A Intravenous administered formulation of spreading hedyotis herb and its preparation method
07/12/2006CN1799565A Medicine for treating piles and its preparing process
07/12/2006CN1799561A Application of Antrodia camphorata mycelium fermented extract in preparation of anti-radiation damage medicine
07/12/2006CN1799536A Bexarotene gel and its preparation method
07/12/2006CN1799414A Health-caring, low cholesterol egg with antioxidant, presenile dementia preventing functions
07/12/2006CN1263852C Extracellular matrix signalling molecules
07/12/2006CN1263770C Novel peptides and medicinal uses thereof
07/12/2006CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives
07/12/2006CN1263733C Substituted phenyl derivatives, their preparation and use
07/12/2006CN1263489C Therapeutic and health-care medicinal hand bag
07/12/2006CN1263487C Oral medicine for treating psora
07/12/2006CN1263486C Ointment for treating burn and scald and its preparation method
07/12/2006CN1263475C Toxicant-expelling and injuries-treating ointment
07/12/2006CN1263474C A topical anti-itch formulation and process for preparation thereof
07/12/2006CN1263461C Cell growth regulating factor F and its preparation process